文献速递消化道肿瘤与早癌消化内镜

粪便免疫化学检测筛查对近端与远端结直肠癌的长期有效性

Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.
PubMed 文献 · Gut · 2021-01-25

FIT筛查使晚期结直肠癌(II期及以上)发病率降低34%(aRR=0.66,95%CI 0.63-0.70),结直肠癌死亡率降低40%(aRR=0.60,95%CI 0.57-0.64),且对远端结直肠癌的长期效果优于近端。

要点

  • FIT筛查使晚期结直肠癌发病率降低34%,死亡率降低40%。
  • FIT筛查对远端晚期癌(aRR=0.61)和死亡(aRR=0.56)效果优于近端(aRR=0.84和0.72)。
  • 结果支持将两年一次FIT组织化筛查作为可持续的人群筛查策略。

核心结论

  • 大规模人群两年一次FIT筛查显著降低晚期结直肠癌发病率和死亡率,对远端结直肠癌的长期效果优于近端。

主要发现

  • FIT筛查组与未筛查组晚期结直肠癌发病率分别为48.4/10万与75.7/10万,死亡率分别为20.3/10万与41.3/10万。
  • FIT筛查使晚期结直肠癌发病率降低34%(aRR=0.66,95%CI 0.63-0.70),结直肠癌死亡率降低40%(aRR=0.60,95%CI 0.57-0.64)。
  • 远端晚期结直肠癌aRR=0.61(95%CI 0.58-0.64),远端结直肠癌死亡aRR=0.56(95%CI 0.53-0.69)。
  • 近端晚期结直肠癌aRR=0.84(95%CI 0.77-0.92),近端结直肠癌死亡aRR=0.72(95%CI 0.66-0.80)。

临床怎么用

  • 支持将两年一次FIT组织化筛查作为可持续的人群结直肠癌筛查策略。
  • 需关注FIT筛查对近端结肠效果较低的问题,探索弥补措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To measure the effects of faecal immunochemical test (FIT) for colorectal cancer (CRC) screening on overall and site-specific long-term effectiveness of population-based organised service screening. DESIGN: A prospective cohort study of Taiwanese nationwide biennial FIT screening was performed. A total of 5 417 699 eligible subjects were invited to attend screening from 2004 through 2009 and were followed up until 2014. We estimated the adjusted relative rates (aRRs) on the effectiveness of reducing advanced-stage CRC (stage II+) and CRC death by Bayesian Poisson regression models with the full adjustment for a cascade of self-selection factors (including the screening rate and the colonoscopy rate) and the completeness of colonoscopy together with demographic features. RESULTS: FIT screening (exposed vs unexposed) reduced the incidence of advanced-stage CRC (48.4 vs 75.7 per 100 000) and mortality (20.3 vs 41.3 per 100 000). Statistically significant reductions of both incidence of advanced-stage CRCs (aRR=0.66, 95% CI 0.63 to 0.70) and deaths from CRC (aRR=0.60, 95% CI 0.57 to 0.64) were noted. FIT screening was more effective in reducing distal advanced-stage CRCs (aRR=0.61, 95% CI 0.58 to 0.64) and CRC mortality (aRR=0.56, 95% CI 0.53 to 0.69) than proximal advanced CRCs (aRR=0.84, 95% CI 0.77 to 0.92) and CRC mortality (aRR=0.72, 95% CI 0.66 to 0.80). CONCLUSION: A large-scale population-based biennial FIT screening demonstrates 34% significant reduction of advanced-stage CRCs and 40% reduction of death from CRC with larger long-term effectiveness in the distal colon than the proximal colon. Our findings provide a strong and consistent evidence-based policy for supporting a sustainable population-based FIT organised service screening worldwide. The disparity of site-specific long-term effectiveness also provides an insight into the remedy for lower effectiveness of FIT screening in the proximal colon.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chiu HM, Jen GH, Wang YW, et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut. 2021. PMID: 33495268. doi:10.1136/gutjnl-2020-322545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。